
Aditi Dutt
Examiner (ID: 10694, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1675, 1649 |
| Total Applications | 612 |
| Issued Applications | 218 |
| Pending Applications | 78 |
| Abandoned Applications | 325 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5236468
[patent_doc_number] => 20070128625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Drug-resistant mutants of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/491756
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4980
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128625.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491756 | Drug-resistant mutants of hepatitis C virus | Jul 23, 2006 | Abandoned |
Array
(
[id] => 4683380
[patent_doc_number] => 20080249606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods for Determining the Effect of a Treatment on the Cross-Beta Structure Content of a Protein; Selection of Treatments and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/995508
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17512
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249606.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995508 | Methods for Determining the Effect of a Treatment on the Cross-Beta Structure Content of a Protein; Selection of Treatments and Uses Thereof | Jul 12, 2006 | Abandoned |
Array
(
[id] => 5075219
[patent_doc_number] => 20070015194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Methods and kits for diagnosing and treating mental retardation'
[patent_app_type] => utility
[patent_app_number] => 11/484719
[patent_app_country] => US
[patent_app_date] => 2006-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 33658
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015194.pdf
[firstpage_image] =>[orig_patent_app_number] => 11484719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/484719 | Methods and kits for diagnosing and treating mental retardation | Jul 11, 2006 | Issued |
Array
(
[id] => 9311805
[patent_doc_number] => 08653023
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-02-18
[patent_title] => 'Dual beneficial effect of dopamine enhancing and neuroprotective actions of PKC delta inhibitors for treatment of Parkinson\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/479173
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 25462
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11479173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/479173 | Dual beneficial effect of dopamine enhancing and neuroprotective actions of PKC delta inhibitors for treatment of Parkinson's disease | Jun 29, 2006 | Issued |
Array
(
[id] => 588976
[patent_doc_number] => 07439328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Tctex-1-related polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/428122
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 85
[patent_no_of_words] => 23254
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11428122
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/428122 | Tctex-1-related polypeptides | Jun 29, 2006 | Issued |
Array
(
[id] => 5141765
[patent_doc_number] => 20070003981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Methods and kits for the diagnosis of acute coronary syndrome'
[patent_app_type] => utility
[patent_app_number] => 11/475249
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11482
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11475249
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/475249 | Methods and kits for the diagnosis of acute coronary syndrome | Jun 26, 2006 | Abandoned |
Array
(
[id] => 5205608
[patent_doc_number] => 20070027090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Methods of treating cognitive dysfunction by modulating brain energy metabolism'
[patent_app_type] => utility
[patent_app_number] => 11/473790
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8728
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027090.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473790 | Methods of treating cognitive dysfunction by modulating brain energy metabolism | Jun 22, 2006 | Abandoned |
Array
(
[id] => 4618746
[patent_doc_number] => 07998460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Prevention of deficits in neurogenesis with anti-inflammatory agents'
[patent_app_type] => utility
[patent_app_number] => 11/473196
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29326
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/998/07998460.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473196
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473196 | Prevention of deficits in neurogenesis with anti-inflammatory agents | Jun 20, 2006 | Issued |
Array
(
[id] => 42776
[patent_doc_number] => 07781396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-24
[patent_title] => 'Peptides directed for diagnosis and treatment of amyloid-associated disease'
[patent_app_type] => utility
[patent_app_number] => 11/471657
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 168
[patent_no_of_words] => 40075
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/781/07781396.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471657
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471657 | Peptides directed for diagnosis and treatment of amyloid-associated disease | Jun 20, 2006 | Issued |
Array
(
[id] => 5446476
[patent_doc_number] => 20090047702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 11/922152
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10529
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047702.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922152
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922152 | Method for Identifying Modulators of Keah6 Useful for Treating Alzheimer's Disease | Jun 13, 2006 | Abandoned |
Array
(
[id] => 9817207
[patent_doc_number] => 08926991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Botulinum toxin and the treatment of primary disorders of mood and affect'
[patent_app_type] => utility
[patent_app_number] => 11/447984
[patent_app_country] => US
[patent_app_date] => 2006-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8458
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11447984
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/447984 | Botulinum toxin and the treatment of primary disorders of mood and affect | Jun 6, 2006 | Issued |
Array
(
[id] => 5056382
[patent_doc_number] => 20070059304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Anti-TrkB monoclonal antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/446875
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 16725
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059304.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446875
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446875 | Anti-TrkB monoclonal antibodies and uses thereof | Jun 4, 2006 | Issued |
Array
(
[id] => 5887562
[patent_doc_number] => 20060275275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Cells and methods for estimation of effects on neurological dysfunction'
[patent_app_type] => utility
[patent_app_number] => 11/442314
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6209
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275275.pdf
[firstpage_image] =>[orig_patent_app_number] => 11442314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/442314 | Cells and methods for estimation of effects on neurological dysfunction | May 29, 2006 | Issued |
Array
(
[id] => 5015749
[patent_doc_number] => 20070258957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Method for obtaining and storing multipotent stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/417719
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3444
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258957.pdf
[firstpage_image] =>[orig_patent_app_number] => 11417719
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/417719 | Method for obtaining and storing multipotent stem cells | May 3, 2006 | Abandoned |
Array
(
[id] => 5075243
[patent_doc_number] => 20070015218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide'
[patent_app_type] => utility
[patent_app_number] => 11/279828
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3149
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015218.pdf
[firstpage_image] =>[orig_patent_app_number] => 11279828
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/279828 | A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide | Apr 13, 2006 | Abandoned |
Array
(
[id] => 5303443
[patent_doc_number] => 20090298095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Immortalization of cells including neuronal cells'
[patent_app_type] => utility
[patent_app_number] => 11/918622
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9064
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20090298095.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918622
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918622 | Immortalization of cells including neuronal cells | Apr 13, 2006 | Abandoned |
Array
(
[id] => 5513425
[patent_doc_number] => 20090213731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'USE OF NEUROPEPTIDE Y (NPY) AND AGONISTS AND ANTAGONISTS THEREOF FOR TISSUE REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 11/911426
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4066
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20090213731.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911426
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911426 | USE OF NEUROPEPTIDE Y (NPY) AND AGONISTS AND ANTAGONISTS THEREOF FOR TISSUE REGENERATION | Apr 9, 2006 | Abandoned |
Array
(
[id] => 5609319
[patent_doc_number] => 20060270835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Diagnosis and treatment of Alzheimer disease'
[patent_app_type] => utility
[patent_app_number] => 11/398889
[patent_app_country] => US
[patent_app_date] => 2006-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 34445
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270835.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398889 | Diagnosis and treatment of Alzheimer disease | Apr 5, 2006 | Abandoned |
Array
(
[id] => 5596233
[patent_doc_number] => 20060160150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Immunoassays for brain natriuretic propeptide'
[patent_app_type] => utility
[patent_app_number] => 11/390404
[patent_app_country] => US
[patent_app_date] => 2006-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11649
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160150.pdf
[firstpage_image] =>[orig_patent_app_number] => 11390404
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/390404 | Immunoassays for brain natriuretic propeptide | Mar 26, 2006 | Abandoned |
Array
(
[id] => 4455507
[patent_doc_number] => 07892751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Method of detecting or diagnosing of a neurodegenerative disease or condition'
[patent_app_type] => utility
[patent_app_number] => 11/359489
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5388
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892751.pdf
[firstpage_image] =>[orig_patent_app_number] => 11359489
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/359489 | Method of detecting or diagnosing of a neurodegenerative disease or condition | Feb 22, 2006 | Issued |